BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 30482492)

  • 1. Low proliferative potential of adipose-derived stromal cells associates with hypertrophy and inflammation in subcutaneous and omental adipose tissue of patients with type 2 diabetes mellitus.
    Stafeev I; Podkuychenko N; Michurina S; Sklyanik I; Panevina A; Shestakova E; Yah'yaev K; Fedenko V; Ratner E; Vorotnikov A; Menshikov M; Yashkov Y; Parfyonova Y; Shestakova M
    J Diabetes Complications; 2019 Feb; 33(2):148-159. PubMed ID: 30482492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.
    Acosta JR; Douagi I; Andersson DP; Bäckdahl J; Rydén M; Arner P; Laurencikiene J
    Diabetologia; 2016 Mar; 59(3):560-70. PubMed ID: 26607638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Omental Adipocyte Hypertrophy and Fibrosis with Human Obesity and Type 2 Diabetes.
    Liu F; He J; Liu B; Zhang P; Wang H; Sun X; Chu X; Guan W; Feng W; Bi Y; Zhu D
    Obesity (Silver Spring); 2021 Jun; 29(6):976-984. PubMed ID: 33943025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.
    Verboven K; Wouters K; Gaens K; Hansen D; Bijnen M; Wetzels S; Stehouwer CD; Goossens GH; Schalkwijk CG; Blaak EE; Jocken JW
    Sci Rep; 2018 Mar; 8(1):4677. PubMed ID: 29549282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity.
    Stafeev I; Sklyanik I; Mamontova E; Michurina S; Shestakova E; Yah'yaev K; Yurasov A; Masnikov D; Sineokaya M; Ratner E; Vorotnikov A; Menshikov M; Parfyonova Y; Shestakova M
    Front Endocrinol (Lausanne); 2021; 12():777589. PubMed ID: 34956089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.
    Tordjman J; Poitou C; Hugol D; Bouillot JL; Basdevant A; Bedossa P; Guerre-Millo M; Clement K
    J Hepatol; 2009 Aug; 51(2):354-62. PubMed ID: 19464069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.
    Lundgren M; Svensson M; Lindmark S; Renström F; Ruge T; Eriksson JW
    Diabetologia; 2007 Mar; 50(3):625-33. PubMed ID: 17216279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes.
    Henninger AM; Eliasson B; Jenndahl LE; Hammarstedt A
    PLoS One; 2014; 9(8):e105262. PubMed ID: 25148116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose Tissue-Derived Stem Cell Sheet Improves Glucose Metabolism in Obese Mice.
    Ishida M; Tatsumi K; Okumoto K; Kaji H
    Stem Cells Dev; 2020 Apr; 29(8):488-497. PubMed ID: 32075539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment.
    Belligoli A; Compagnin C; Sanna M; Favaretto F; Fabris R; Busetto L; Foletto M; Dal Prà C; Serra R; Prevedello L; Da Re C; Bardini R; Mescoli C; Rugge M; Fioretto P; Conci S; Bettini S; Milan G; Vettor R
    Sci Rep; 2019 Aug; 9(1):11333. PubMed ID: 31383894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.
    Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J
    Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals.
    Al-Sulaiti H; Diboun I; Banu S; Al-Emadi M; Amani P; Harvey TM; Dömling AS; Latiff A; Elrayess MA
    J Transl Med; 2018 Jun; 16(1):175. PubMed ID: 29940972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
    Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages of the subcutaneous and omental fatty tissue in obese patients: Immunohistochemical phenotyping of M2 subtypes in relation to type 2 diabetes.
    Chylikova J; Dvorackova J; Cizkova K; Lacey H; Kamarad V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):133-137. PubMed ID: 30967686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients.
    Jaganjac M; Almuraikhy S; Al-Khelaifi F; Al-Jaber M; Bashah M; Mazloum NA; Zarkovic K; Zarkovic N; Waeg G; Kafienah W; Elrayess MA
    Redox Biol; 2017 Aug; 12():483-490. PubMed ID: 28334683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.
    Eriksson-Hogling D; Andersson DP; Bäckdahl J; Hoffstedt J; Rössner S; Thorell A; Arner E; Arner P; Rydén M
    Int J Obes (Lond); 2015 Jun; 39(6):893-8. PubMed ID: 25666530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased UCP-1 expression in beige adipocytes from adipose-derived stem cells of type 2 diabetes patients associates with mitochondrial ROS accumulation during obesity.
    Michurina S; Stafeev I; Podkuychenko N; Sklyanik I; Shestakova E; Yah'yaev K; Yurasov A; Ratner E; Menshikov M; Parfyonova Y; Shestakova M
    Diabetes Res Clin Pract; 2020 Nov; 169():108410. PubMed ID: 32882342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
    Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
    Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.